Diabetic Polyneuropathy. Diabetic Polyneuropathy
Conditions
Interventions
Intervention 1: Duloxetine: Dose: 30 mg
Number of using: Forty-two times(once a day)
Factory name: Tadbir Kalay-e Jam Company
Manufacturing Country's Name: Iran
Administration: Orally
Administration time: Every day. Intervention 2: Nortriptyline:
Dose: 25 mg
Factory name: Daroupakhsh Company
Administration time: Every day.
Treatment - Drugs
Duloxetine: Dose: 30 mg
Administration time: Every day
Nortriptyline:
Dose: 25 mg
Sponsors
Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age greater than 18 years; diabetes type one or two; 24-hour average pain score greater than 40 millimeter; Michigan neuropathy screening instrument scores by at least 3; and electrophysiological findings indicate neuropathy Exclusion criteria: Mood disorder; drug and alcohol abuse; history of epilepsy; pregnant women; peripheral vessels disease; and history of diabetes less than a year
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Every week for six weeks. Method of measurement: visual Analogue Scale Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drugs side effects. Timepoint: Every week for six weeks. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Amiri
Ahvaz Jundishapour University of Medical Sciences
Outcome results
None listed